Close Menu

NEW YORK (GenomeWeb) – Epigenomics of Germany said today that it has terminated its collaboration with China's BioChain for the licensing of the Septin9 marker and exclusive Chinese distribution rights for Epi proColon, Epigenomics' blood test for colorectal cancer.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers representing scientists and students of Chinese descent voice their concerns about recent US policies and rhetoric.

Wired reports that researchers have shown they could reprogram a DNA-based computer.

Researchers say increased diversity in genomic studies will benefit all, PBS NewsHour reports.

In Science this week: whole-genome sequencing of single sperm cells, and more.